Binding of transition metal ions to albumin: Sites, affinities and rates

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 12, 2013, Pages 5444-5455

  Bal, Wojciech ^a   Sokołowska, Magdalena ^a   Kurowska, Ewa ^a   Faller, Peter ^b,c  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^b LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Albumin; Binding constants; Metal ions

Indexed keywords

AMYLOID BETA PROTEIN; CADMIUM; COBALT; COPPER; CUPRIC ION; GOLD; HUMAN SERUM ALBUMIN; IRON; MERCURY; METAL ION; NICKEL; PLATINUM; VANADIUM; ZINC ION;

AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; BINDING AFFINITY; BINDING SITE; CALORIMETRY; CIRCULAR DICHROISM; DISSOCIATION CONSTANT; ELECTRON SPIN RESONANCE; EQUILIBRIUM DIALYSIS; FLUORESCENCE SPECTROSCOPY; HUMAN; METAL BINDING; MOLECULAR INTERACTION; MOLECULAR STABILITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; POTENTIOMETRY; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW;

ALBUMIN; BINDING CONSTANTS; METAL IONS;

BINDING SITES; KINETICS; METALS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN BINDING; SERUM ALBUMIN;

EID: 84885375220     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.06.018     Document Type: Review

References (161)

1. F.A. Cotton, G. Wilkinson, and P.L. Gauss Basic Inorganic Chemistry 3rd ed. 1995 Wiley
2. L. Davidsson, B. Lönnerdal, B. Sandström, C. Kunz, and C.L. Keen Identification of transferrin as the major plasma carrier protein for manganese introduced orally or intravenously or after in vitro addition in the rat J. Nutr. 119 1989 1461 1464 (Pubitemid 20001507)
3. J.B. Vincent The biochemistry of chromium J. Nutr. 130 2000 715 718 (Pubitemid 30173651)
4. M. Cazzola, H.A. Huebers, M.H. Sayers, P. MacPhail, M. Eng, and C.A. Finch Transferrin saturation, plasma iron turnover, and transferrin uptake in normal humans Blood 66 1985 935 939 (Pubitemid 15242481)
5. A.M.N. Silva, and R.C. Hider Influence of non-enzymatic post-translation modifications on the ability of human serum albumin to bind iron. implications for non-transferrin-bound iron speciation Biochim. Biophys. Acta 1794 2009 1449 1458
6. J.T. Rubino, and K.J. Franz Coordination chemistry of copper proteins: how nature handles a toxic cargo for essential function J. Inorg. Biochem. 107 2012 129 143
7. L. Banci, I. Bertini, S. Ciofi-Baffoni, T. Kozyreva, K. Zovo, and P. Palumaa Affinity gradients drive copper to cellular destinations Nature 465 2010 (645-U145)
8. I. Zaitseva, V. Zaitsev, G. Card, K. Moshkov, B. Bax, A. Ralph, and P. Lindley The X-ray structure of human serum ceruloplasmin at 3.1 Å: nature of the copper centres J. Biol. Inorg. Chem. 1 1996 15 23 (Pubitemid 126489977)
9. W. Maret New perspectives of zinc coordination environments in proteins J. Inorg. Biochem. 111 2012 110 116
10. W. Maret, and Y. Li Coordination dynamics of zinc in proteins Chem. Rev. 109 2009 4682 4707
11. J. Lu, A.J. Stewart, D. Sleep, P.J. Sadler, T.J. Pinheiro, and C.A. Blindauer A molecular mechanism for modulating plasma Zn speciation by fatty acids J. Am. Chem. Soc. 134 2012 1454 1457
12. L.O. Simonsen, H. Harbak, and P. Bennekou Cobalt metabolism and toxicology - a brief update Sci. Total Environ. 432 2012 210 215
13. 2 + binding by plasma albumin Biochem. Med. 9 1974 177 183
14. K. Merritt, S.A. Brown, and N.A. Sharkey The binding of metal salts and corrosion products to cells and proteins in vitro J. Biomed. Mater. Res. 18 1984 1005 1015 (Pubitemid 15425884)
15. II) with native and modified bovine serum albumins J. Am. Chem. Soc. 80 1958 3226 3235
16. II with bovine serum albumin J. Am. Chem. Soc. 81 1959 844 848
17. I.M. Kolthoff, and B.R. Willeford Jr. The interaction of copper(II) with bovine serum albumin J. Am. Chem. Soc. 80 1958 5673 5678
18. A.D. Sheftel, A.B. Mason, and P. Ponka The long history of iron in the universe and in health and disease Biochim. Biophys. Acta 1820 2012 161 187
19. A.T. McKie, P. Marciani, A. Rolfs, K. Brennan, K. Wehr, D. Barrow, S. Miret, A. Bomford, T.J. Peters, F. Farzaneh, M.A. Hediger, M.W. Hentze, and R.J. Simpson A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation Mol. Cell 5 2000 299 309 (Pubitemid 30628088)
20. E. Kurowska, and W. Bal Recent advances in molecular toxicology of cadmium and nickel James C. Fishbein, Advances in molecular toxicology vol. 4 2010 Elsevier B.V. 85 126 (Chapter 3)
21. E.L. Carter, N. Flugga, J.L. Boer, S.B. Mulrooney, and R.P. Hausinger Interplay of metal ions and urease Metallomics 1 2009 207 221
22. F.W. Sunderman Jr. Potential toxicity from nickel contamination of intravenous fluids Ann. Clin. Lab. Sci. 13 1983 1 4 (Pubitemid 13175341)
23. 2 + J. Am. Chem. Soc. 115 1993 9285 9286
24. A.R. Soto, H. Zheng, D. Shoemaker, J. Rodriguez, B.A. Read, and T.M. Wahlund Identification and preliminary characterization of two cDNAs encoding unique carbonic anhydrases from the marine alga Emiliania huxleyi Appl. Environ. Microbiol. 72 2006 5500 5511
25. J.M. Berg, and H.A. Godwin Lessons from zinc-binding peptides Annu. Rev. Biophys. Biomol. Struct. 26 1997 357 371 (Pubitemid 27255377)
26. B.J. Scott, and A.R. Bradwell Identification of the serum binding proteins for iron, zinc, cadmium, nickel, and calcium Clin. Chem. 29 1983 629 633 (Pubitemid 13109697)
27. 113Cd NMR study Inorg. Chim. Acta 67 1982 71 74
28. E. Kopera, T. Schwerdtle, A. Hartwig, and W. Bal Co(II) and Cd(II) substitute for Zn(II) in the zinc finger derived from the DNA repair protein XPA, demonstrating a variety of potential mechanisms of toxicity Chem. Res. Toxicol. 17 2004 1452 1458 (Pubitemid 39532314)
29. M. Farina, J.B. Rocha, and M. Aschner Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies Life Sci. 89 2011 555 563
30. S. Trümpler, W. Lohmann, B. Meermann, W. Buscher, M. Sperling, and U. Karst Interaction of thimerosal with proteins - ethylmercury adduct formation of human serum albumin and β-lactoglobulin A Metallomics 1 2009 87 91
31. E. Kiss, I. Fabian, and T. Kiss Kinetics of ligand substitution reactions in the oxovanadium(IV)-maltol system Inorg. Chim. Acta 340 2002 114 118
32. Y. Shechter, I. Goldwaser, M. Mironchik, M. Fridkin, and D. Gefel Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes Coord. Chem. Rev. 237 2003 3 11
33. T. Jakusch, J. Costa Pessoa, and T. Kiss The speciation of vanadium in human serum Coord. Chem. Rev. 255 2011 2218 2226
34. H. Yasui, K. Takechi, and H. Sakurai Metallokinetic analysis of disposition of vanadyl complexes as insulin-mimetics in rats using BCM-ESR method J. Inorg. Biochem. 78 2000 185 196 (Pubitemid 30628473)
35. T. Kiss, T. Jakusch, D. Hollender, Á. Dörnyei, É.A. Enyedy, J. Costa Pessoa, H. Sakurai, and A. Sanz-Medel Biospeciation of antidiabetic VO(IV) complexes Coord. Chem. Rev. 252 2008 1153 1162
36. J. Costa Pessoa, and I. Tomaz Transport of therapeutic vanadium and ruthenium complexes by blood plasma components Curr. Med. Chem. 17 2010 3701 3738
37. P.N. Dickson, A. Wehrli, and G. Geier Coordination chemistry of gold(I) with cyanide and 1-methylpyridine-2-thione. Kinetics and thermodynamics of ligand exchange at gold(I) in aqueous solution Inorg. Chem. 27 1988 2921 2925
38. W. Robb Kinetics and mechanisms of reactions of gold(III) complexes. I. The equilibrium hydrolysis of tetrachlorogold(III) in acid medium Inorg. Chem. 6 1967 382 386
39. S.J. Berners-Price, and A. Filipovska Gold compounds as therapeutic agents for human diseases Metallomics 3 2011 863 873
40. I. Ott On the medicinal chemistry of gold complexes as anticancer drugs Coord. Chem. Rev. 253 2009 1670 1681
41. S.J. Tan, Y.K. Yan, P.P. Lee, and K.H. Lim Copper, gold and silver compounds as potential new anti-tumor metallodrugs Future Med. Chem. 2 2010 1591 1608
42. A. Casini, G. Kelter, C. Gabbiani, M.A. Cinellu, G. Minghetti, D. Fregona, H.-H. Fiebig, and L. Messori Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study J. Biol. Inorg. Chem. 14 2009 1139 1149
43. J.D. Herrlinger, and W. Weikert Protein binding of gold in serum of patients treated with different gold preparations Z. Rheumatol. 415 1982 230 234 (Pubitemid 12005531)
44. M.S. Iqbal, S.G. Taqi, M. Arif, M. Wasim, and M. Sher In vitro distribution of gold in serum proteins after incubation of sodium aurothiomalate and auranofin with human blood and its pharmacological significance Biol. Trace Elem. Res. 130 2009 204 209
45. L. Messori, A. Balerna, I. Ascone, C. Castellano, C. Gabbiani, A. Casini, C. Marchioni, G. Jaouen, and A. Congiu Castellano X-ray absorption spectroscopy studies of the adducts formed between cytotoxic gold compounds and two major serum proteins J. Biol. Inorg. Chem. 16 2011 491 499
46. S.H. van Rijt, and P.J. Sadler Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs Drug Discov. Today 14 2009 1089 1097
47. S. Dhar, N. Kolishetti, S.J. Lippard, and O.C. Farokhzad Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo Proc. Natl. Acad. Sci. U. S. A. 108 2011 1850 1855
48. B.T. Benedetti, E.J. Peterson, P. Kabolizadeh, A. Martínez, R. Kipping, and N.P. Farrell Effects of noncovalent platinum drug-protein interactions on drug efficacy: use of fluorescent conjugates as probes for drug metabolism Mol. Pharm. 8 2011 940 948
49. M. Vasak, J.H.R. Kaegi, and H.A.O. Hill Zinc(II), cadmium(II), and mercury(II) thiolate transitions in metallothionein Biochemistry 20 1981 2852 2856
50. K. Hirose A practical guide for the determination of binding constants J. Incl. Phenom. Macro. Chem. 39 2001 193 209 (Pubitemid 33654898)
51. N.E. Grossoehme, A.M. Spuches, and D.E. Wilcox Application of isothermal titration calorimetry in bioinorganic chemistry J. Biol. Inorg. Chem. 15 2010 1183 1191
52. T. Peters Jr. Serum albumin Adv. Protein Chem. 37 1985 161 245
53. W. Bal, M. Jeżowska-Bojczuk, and K.S. Kasprzak Binding of nickel(II) and copper(II) to the N-terminal sequence of human protamine HP2 Chem. Res. Toxicol. 10 1997 906 914 (Pubitemid 27350050)
54. R.F. Chen Fluorescence quantum yields of tryptophan and tyrosine Anal. Lett. 1 1967 35 42
55. M.R. Eftink Fluorescence quenching: theory and applications Top. Fluoresc. Spectrosc. 2 2002 53 126
56. M.R. Eftink Fluorescence techniques for studying protein structure Methods Biochem. Anal. 35 1991 127 205
57. D.C. Carter, and J.X. Ho Structure of serum albumin Adv. Protein Chem. 45 1994 153 203 (Pubitemid 24139888)
58. L. Trynda-Lemiesz, H. Kozłowski, and B.K. Keppler Effect of cis-, trans-diamminedichloroplatinum(II) and DBP on human serum albumin J. Inorg. Biochem. 77 1999 141 146 (Pubitemid 30047063)
59. N. Ohta, D. Chen, S. Ito, T. Futo, T. Yotsuyanagi, and K. Ikeda Effect of trans-diamminedichloroplatinum(II) on human serum albumin: conformational changes through partial disulfide bond cleavage Int. J. Pharm. 118 1995 85 93
60. E. Mothes, and P. Faller Evidence that the principal Co(II)-binding site in human serum albumin is not at the N-Terminus: implication on the albumin cobalt binding test for detecting myocardial ischemia Biochemistry 46 2007 2267 2274 (Pubitemid 46355336)
61. 3 + Eur. J. Biochem. 220 1994 193 200 (Pubitemid 24067569)
62. (2 +) Inorg. Chem. 35 1996 4490 4496 (Pubitemid 126451901)
63. 113Cd-NMR study Biochem. Cell Biol. 69 1991 809 820
64. A.J. Stewart, C.A. Blindauer, S. Berezenko, D. Sleep, and P.J. Sadler Interdomain zinc site on human albumin Proc. Natl. Acad. Sci. U. S. A. 100 2003 3701 3706 (Pubitemid 36418095)
65. C. Harford, and B. Sarkar Amino terminal Cu(II) and Ni (II)-binding (ATCUN) motif of proteins and peptides Acc. Chem. Res. 30 1997 123 130
66. A. Braibanti, G. Ostacoli, P. Paoletti, L.D. Pettit, and S. Sammartano Recommended procedure for testing the potentiometric apparatus and technique for the testing of pH-metric measurement of metal-complex equilibrium constants Pure Appl. Chem. 59 1987 1721 1728
67. T. Kiss, T. Jakusch, B. Gyurcsik, A. Lakatos, É.A. Enyedy, and É. Sija Application of modeling calculations in the description of metal ion distribution of bioactive compounds in biological systems Coord. Chem. Rev. 256 2012 125 132
68. K. Burger, F. Gaizer, B. Noszál, M. Pékli, and G. Takácsi-Nagy Coordination-chemistry study of polypeptides. III. Protonation-deprotonation equilibrium study of synthetic alpha H-corticotropin 1-32. Data on the pH-dependent conformation of corticotropin Bioinorg. Chem. 7 1977 335 344 (Pubitemid 8242922)
69. L.A. Byrne, M.J. Hynes, C.D. Connolly, and R.A. Murphy Analytical determination of apparent stability constants using a copper ion selective electrode J. Inorg. Biochem. 105 2011 1656 1661
70. G. Scatchard The attraction of proteins for small molecules and ions Ann. N. Y. Acad. Sci. 51 1949 660 672
71. J. Masuoka, and P. Saltman Zinc(II) and copper(II) binding to serum albumin. a comparative study of dog, bovine, and human albumin J. Biol. Chem. 269 1994 25557 25561
72. D. Shcharbin, J. Mazur, M. Szwedzka, M. Wasiak, B. Palecz, M. Przybyszewska, M. Zaborski, and M. Bryszewska Interaction between PAMAM 4.5 dendrimer, cadmium and bovine serum albumin: a study using equilibrium dialysis, isothermal titration calorimetry, zeta-potential and fluorescence Colloids Surf. B Biointerfaces 58 2007 286 289 (Pubitemid 46921468)
73. (+) and human serum albumin J. Inorg. Biochem. 95 2003 124 130 (Pubitemid 36579384)
74. K.A. Majorek, P.J. Porebski, A. Dayal, M.D. Zimmerman, K. Jablonska, A.J. Stewart, M. Chruszcz, and W. Minor Structural and immunologic characterization of bovine, horse, and rabbit serum albumins Mol. Immunol. 52 2012 174 182
75. X.M. He, and D.C. Carter Atomic structure and chemistry of human serum albumin Nature 358 1992 209 215
76. S. Curry, H. Mandelkow, P. Brick, and N. Franks Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites Nat. Struct. Biol. 5 1998 827 835 (Pubitemid 28402087)
77. S. Sugio, A. Kashima, S. Mochizuki, M. Noda, and K. Kobayashi Crystal structure of human serum albumin at 2.5 a resolution Protein Eng. 12 1999 439 446 (Pubitemid 29322441)
78. C.A. Blindauer, J. Lu, A.J. Stewart, P.J. Sadler, and T.J.T. Pinheiro Albumin as a zinc carrier: properties of its high-affinity zinc-binding site Biochem. Soc. Trans. 36 2008 1317 1321
79. D.W. Appleton, and B. Sarkar The absence of specific copper(II)-binding site in dog albumin J. Biol. Chem. 246 1971 5040 5046
80. P.F. Predki, C. Harford, P. Brar, and B. Sarkar Further characterization of the N-terminal copper(II)- and nickel(II)-binding motif of proteins. studies of metal binding to chicken serum albumin and the native sequence peptide Biochem. J. 287 1992 211 215
81. H. Kozlowski, W. Bal, M. Dyba, and T. Kowalik-Jankowska Specific structure-stability relations in metallopeptides Coord. Chem. Rev. 184 1999 319 346
82. M. Sokołowska, A. Krȩżel, M. Dyba, Z. Szewczuk, and W. Bal Short peptides are not reliable models of thermodynamic and kinetic properties of the N-terminal metal binding site in serum albumin Eur. J. Biochem. 269 2002 1323 1331 (Pubitemid 34175393)
83. M.C. Linder, and M. Hazegh-Azam Copper biochemistry and molecular biology Am. J. Clin. Nutr. 63 1996 797S 811S (Pubitemid 26126602)
84. N.F. Suttle Copper imbalances in ruminants and humans: unexpected common ground Adv. Nutr. 3 2012 666 674
85. W.M. Brown, K.M. Dziegielewska, R.C. Foreman, and N.R. Saunders Nucleotide and deduced amino acid sequence of sheep serum albumin Nucl. Acids Res. 17 1989 10495 (Pubitemid 20012205)
86. M. Rózga, M. Sokołowska, A.M. Protas, and W. Bal Human serum albumin coordinates Cu(II) at its N-terminal binding site with one picomolar affinity J. Biol. Inorg. Chem. 12 2007 913 918 (Pubitemid 47174879)
87. S.D. Lewis, D.C. Misra, and J.A. Shafer Determination of interactive thiol ionizations in bovine serum albumin, glutathione, and other thiols by potentiometric difference titration Biochemistry 19 1980 6129 6137
88. G.C. Tong, W.K. Cornwell, and G.E. Means Reactions of acrylamide with glutathione and serum albumin Toxicol. Lett. 147 2004 127 131 (Pubitemid 38130181)
89. M. Sogami, S. Era, S. Nagaoka, K. Kuwata, K. Kida, and K. Miura HPLC-studies on Nonmercapt-Mercapt conversion of human serum albumin Int. J. Pept. Protein Res. 25 1985 398 402 (Pubitemid 15105110)
90. J.S. Stamler, O. Jaraki, J. Osborne, D.I. Simon, J. Keaney, J. Vita, D. Singel, C.R. Valeri, and J. Loscalzo Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin Proc. Natl. Acad. Sci. U. S. A. 89 1992 7674 7677
91. C.A. Blindauer, I. Harvey, K.E. Bunyan, A.J. Stewart, D. Sleep, D.J. Harrison, S. Berezenko, and P.J. Sadler Structure, properties, and engineering of the major zinc binding site on human albumin J. Biol. Chem. 284 2009 23116 23124
92. W. Bal, J. Christodoulou, P.J. Sadler, and A. Tucker Multi-metal binding site of serum albumin J. Inorg. Biochem. 70 1998 33 39 (Pubitemid 28340621)
93. 1H-NMR relaxometric study J. Inorg. Biochem. 117 2012 198 203
94. A. Zgirski, and E. Frieden Binding of Cu(II) to non-prosthetic sites in ceruloplasmin and bovine serum albumin J. Inorg. Biochem. 39 1990 137 148 (Pubitemid 20202650)
95. M. Sokołowska, K. Pawlas, and W. Bal Effect of common buffers and heterocyclic ligands on the binding of Cu(II) at the multimetal binding site in human serum albumin Bioinorg. Chem. Appl. 2010 7 (Article ID 725153)
96. E. Ohyoshi, Y. Hamada, K. Nakata, and S. Kohata The interaction between human and bovine serum albumin and zinc studied by a competitive spectrophotometry J. Inorg. Biochem. 75 1999 213 218 (Pubitemid 29398723)
97. M. Sokołowska, M. Wszelaka-Rylik, J. Poznański, and W. Bal Spectroscopic and thermodynamic determination of three distinct binding sites for Co(II) ions in human serum albumin J. Inorg. Biochem. 103 2009 1005 1013
98. H. Lakusta, and B. Sarkar Equilibrium studies of zinc(II) and cobalt(II) binding to tripeptide analogues of the amino terminus of human serum albumin J. Inorg. Biochem. 11 1979 303 315 (Pubitemid 10185291)
99. S.H. Laurie, and D.E. Pratt A spectroscopic study of nickel(II)-bovine serum albumin binding and reactivity J. Inorg. Biochem. 28 1986 431 439
100. J. Dolovich, S.L. Evans, and E. Nieboer Occupational asthma from nickel sensitivity: I human serum albumin in the antigenic determinant Br. J. Ind. Med. 41 1984 51 55 (Pubitemid 14093258)
101. S. Wöhrl, W. Hemmer, M. Focke, M. Götz, and R. Jarisch Copper allergy revisited J. Am. Acad. Dermatol. 45 2001 863 870 (Pubitemid 33096626)
102. P. Leverrier, C. Montigny, M. Garrigos, and P. Champeil Metal binding to ligands: cadmium complexes with glutathione revisited Anal. Biochem. 371 2007 215 228 (Pubitemid 350019445)
103. S. Ogawa, and E. Yoshimura Determination of thermodynamic parameters of cadmium(II) association to glutathione using the fluorescent reagent FluoZin-1 Anal. Biochem. 402 2010 200 202
104. S. Lau, and B. Sarkar Inorganic mercury(II)-binding components in normal human blood serum J. Toxicol. Environ. Health 5 1979 907 916 (Pubitemid 10191779)
105. Y. Zhou, X. Hu, C. Dou, H. Liu, S. Wang, and P. Shen Structural studies on metal-serum albumin. IV. The interaction of Zn(II), Cd(II) and Hg(II) with HSA and BSA Biophys. Chem. 42 1992 201 211
106. Y. Li, X.P. Yan, C. Chen, Y.L. Xia, and Y. Jiang Human serum albumin-mercurial species interactions J. Proteome Res. 6 2007 2277 2286 (Pubitemid 46985115)
107. G.R. Hanson, B.D. Liboiron, K.H. Thompson, E. Lam, N. Aebischer, and C. Orvig New Insights into the Interactions of Serum Proteins with Bis(maltolato)oxovanadium(IV): Transport and Biotransformation of Insulin-Enhancing Vanadium Pharmaceuticals J. Am. Chem. Soc. 127 2005 5104 5115 (Pubitemid 40523470)
108. N.D. Chasteen, and J. Francavilla An electron paramagnetic resonance study of vanadyl(IV)-serum albumin complexes J. Phys. Chem. 80 1976 867 871
109. I. Correia, T. Jakusch, E. Cobbinna, S. Mehtab, I. Tomaz, N.V. Nagy, A. Rockenbauer, J. Costa Pessoa, and T. Kiss Evaluation of the binding of oxovanadium(IV) to human serum albumin Dalton Trans. 41 2012 6477 6487
110. D. Sanna, E. Garribba, and G. Micera Interaction of VO2 + ion with human serum transferrin and albumin J. Inorg. Biochem. 103 2009 648 655
111. T. Kiss, T. Jakusch, J.C. Pessoa, and I. Tomaz Interactions of VO(IV) with oligopeptides Coord. Chem. Rev. 237 2003 123 133
112. E. Garribba, D. Sanna, P. Buglyo, and G. Micera J. Biol. Inorg. Chem. 15 2010 825 839
113. C.F. Shaw III The protein chemistry of antiarthritic gold(I) thiolates and related complexes Comments Inorg. Chem. 8 1989 233 267
114. 1H NMR studies of gold binding and cysteine release J. Am. Chem. Soc. 114 1992 1117 1118
115. 1H-NMR spectroscopy Eur. J. Biochem. 225 1994 363 368 (Pubitemid 24306262)
116. J.R. Roberts, J. Xiao, B. Schliesman, D.J. Parsons, and C.F. Shaw III Kinetics and mechanism of the reaction between serum albumin and auranofin (and its isopropyl analogue) in vitro Inorg. Chem. 35 1996 424 433 (Pubitemid 126458672)
117. B.P. Esposito, and R. Najjar Interactions of antitumoral platinum-group metallodrugs with albumin Coord. Chem. Rev. 232 2002 137 149
118. A.I. Ivanov, J. Christodoulou, J.A. Parkinson, K.J. Barnham, A. Tucker, J. Woodrow, and P.J. Sadler Cisplatin binding sites on human albumin J. Biol. Chem. 273 1998 14721 14730 (Pubitemid 28272756)
119. J.F. Neault, and H.A. Tajmir-Riahi Interaction of cisplatin with human serum albumin. drug binding mode and protein secondary structure Biochim. Biophys. Acta 1384 1998 153 159 (Pubitemid 28193025)
120. S.S. Aleksenko, C.G. Hartinger, O. Semenova, K. Meelich, A.R. Timerbaev, and B.K. Keppler Characterization of interactions between human serum albumin and tumor-inhibiting amino alcohol platinum(II) complexes using capillary electrophoresis J. Chromatogr. A 1155 2007 218 221 (Pubitemid 46898407)
121. Y. Wang, X. Wang, J. Wang, Y. Zhao, W. He, and Z. Guo Noncovalent interactions between a trinuclear monofunctional platinum complex and human serum albumin Inorg. Chem. 50 2011 12661 12668
122. F. Samari, B. Hemmateenejad, M. Shamsipur, M. Rashidi, and H. Samouei Affinity of two novel five-coordinated anticancer Pt(II) complexes to human and bovine serum albumins: a spectroscopic approach Inorg. Chem. 51 2012 3454 3464
123. M.D. Hall, and T.W. Hambley Platinum(IV) antitumour compounds: their bioinorganic chemistry Coord. Chem. Rev. 232 2002 49 67
124. 2 + binding to the DAHK and GHK peptides by isothermal titration calorimetry (ITC) J. Biol. Inorg. Chem. 17 2012 37 47
125. E. Kurowska, A. Bonna, G. Goch, and W. Bal Salivary histatin-5, a physiologically relevant ligand for ni(II) ions J. Inorg. Biochem. 105 2011 1220 1225
126. G. Gasmi, A. Singer, J. FormanKay, and B. Sarkar NMR structure of neuromedin c, a neurotransmitter with an amino terminal Cu-II-, Ni-II-binding (ATCUN) motif J. Pept. Res. 49 1997 500 509 (Pubitemid 27334994)
127. C. Harford, and B. Sarkar Neuromedin C binds Cu(II) and Ni(II) via the ATCUN motif: implications for the CNS and cancer growth Biochem. Biophys. Res. Commun. 209 1995 877 882
128. C. Tselepis, S.J. Ford, A.T. McKie, W. Vogel, H. Zoller, R.J. Simpson, J. Diaz Castro, T.H. Iqbal, and D.G. Ward Characterization of the transition-metal-binding properties of hepcidin Biochem. J. 427 2010 289 296
129. N. Camerman, A. Camerman, and B. Sarkar Molecular design to mimic the copper(II) transport site of human albumin. The crystal and molecular structure of copper(II)-glycylglycyl-l-histidine-N-methyl amide monoaquo complex Can. J. Chem. 54 1976 1309 1316
130. II(Glycyl Glycyl α-hydroxy D,L histamine)]3H2O J. Chem. Soc. Chem. Commun. 1889 1994 1890
131. C. Hureau, H. Eury, R. Guillot, C. Bijani, S. Sayen, P.L. Solari, E. Guillon, P. Faller, and P. Dorlet X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties Chemistry 17 2011 10151 10160
132. W. Bal, G.N. Chmurny, B.D. Hilton, P.J. Sadler, and A. Tucker Axial hydrophobic fence in highly stable Ni(II) complex of des-angiotensinogen N-terminal peptide J. Am. Chem. Soc. 118 1996 4727 4728 (Pubitemid 26180040)
133. W. Bal, J. Wójcik, M. Maciejczyk, P. Grochowski, and K.S. Kasprzak Induction of a secondary structure in the N-terminal pentadecapeptide of human protamine HP2 through Ni(II) coordination. An NMR study Chem. Res. Toxicol. 13 2000 823 830
134. M.R. McDonald, W.M. Scheper, H.D. Lee, and D.W. Margerum Copper(III) complexes of tripeptides with histidine and histamine as the third residue Inorg. Chem. 34 1995 229 237
135. L. Perrone, E. Mothes, M. Vignes, A. Mockel, C. Figueroa, M.C. Miquel, M.L. Maddelein, and P. Faller Copper transfer from Cu-Abeta to human serum albumin inhibits aggregation, radical production and reduces Abeta toxicity Chembiochem 11 2010 110 118
136. K.L. Haas, A.B. Putterman, D.R. White, D.J. Thiele, and K.J. Franz Model peptides provide new insights into the role of histidine residues as potential ligands in human cellular copper acquisition via Ctr1 J. Am. Chem. Soc. 133 2011 4427 4437
137. W. Bal, J. Lukszo, and K.S. Kasprzak Mediation of oxidative DNA damage by nickel(II) and copper(II) complexes with the N-terminal sequence of human protamine HP2 Chem. Res. Toxicol. 10 1997 915 921 (Pubitemid 27350051)
138. N. Cotelle, E. Tremolieres, J.L. Bernier, J.P. Catteau, and J.P. Henichart Redox chemistry of complexes of nickel(II) with some biologically important peptides in the presence of reduced oxygen species: an ESR study J. Inorg. Biochem. 46 1992 7 15
139. E. Nieboer, P.I. Stetsko, and P.Y. Hin Characterization of the Ni(III)/Ni(II) redox couple for the nickel(II) complex of human serum albumin Ann. Clin. Lab. Sci. 14 1984 409
140. D.P. Mack, and P.B. Dervan Sequence-specific oxidative cleavage of DNA by a designed metalloprotein, Ni(II).GGH(Hin139-190) Biochemistry 31 1992 9399 9405
141. C. Harford, S. Narindrasorasak, and B. Sarkar The designed protein M(II)-Gly-Lys-His-Fos(138-211) specifically cleaves the AP-1 binding site containing DNA Biochemistry 35 1996 4271 4278 (Pubitemid 26113486)
142. Y.-Y. Fang, B.D. Ray, C.A. Claussen, K.B. Lipkowitz, and E.C. Long Ni(II) · Arg-Gly-His - DNA interactions: investigation into the basis for minor-groove binding and recognition J. Am. Chem. Soc. 126 2004 5403 5412 (Pubitemid 38596352)
143. E.C. Long, Y.-Y. Fang, and M.A. Lewis DNA minor groove recognition by Ni(II)• and Cu(II)•Gly-Gly-His derived metallopeptides: models of protein and natural product DNA recognition ACS Symp. Ser. 1012 2009 219 241
144. 1H NMR of albumin in human blood plasma: drug binding and redox reactions at Cys34 FEBS Lett. 376 1995 1 5 (Pubitemid 3003746)
145. (2 +) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia Eur. J. Biochem. 268 2001 42 47 (Pubitemid 32054374)
146. D. Bar-Or, E. Lau, and J.V. Winkler A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - a preliminary report J. Emerg. Med. 19 2000 311 315
147. R.H. Christenson, S.H. Duh, W.R. Sanhai, A.H. Wu, V. Holtman, P. Painter, E. Branham, F.S. Apple, M. Murakami, and D.L. Morris Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study Clin. Chem. 47 2001 464 470 (Pubitemid 32222460)
148. D. Bar-Or, J.V. Winkler, K. Vanbenthuysen, L. Harris, E. Lau, and F.W. HetzelReduced Albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I Am. Heart J. 141 2001 985 991
149. N.V. Bhagavan, E.M. Lai, P.A. Rios, J. Yang, A.M. Ortega-Lopez, H. Shinoda, S.A. Honda, C.N. Rios, C.E. Sugiyama, and C.E. Ha Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction Clin. Chem. 49 2003 581 585 (Pubitemid 36379523)
150. F.S. Apple Clinical and analytical review of ischemia-modified albumin measured by the albumin cobalt binding test Adv. Clin. Chem. 39 2005 1 10 (Pubitemid 43588711)
151. B.J. Oh, M.H. Seo, and H.S. Kim Insignificant role of the N-terminal cobalt-binding site of albumin in the assessment of acute coronary syndrome: discrepancy between the albumin cobalt-binding assay and N-terminal-targeted immunoassay Biomarkers 17 2012 394 401
152. J. Lu, A.J. Stewart, P.J. Sadler, T.J. Pinheiro, and C.A. Blindauer Allosteric inhibition of cobalt binding to albumin by fatty acids: implications for the detection of myocardial ischemia J. Med. Chem. 55 2012 4425 4430
153. G.D. Lopaschuk, J.R. Ussher, C.D. Folmes, J.S. Jaswal, and W.C. Stanley Myocardial fatty acid metabolism in health and disease Physiol. Rev. 90 2010 207 258
154. P. Faller, and C. Hureau A bioinorganic view of Alzheimer's disease: when misplaced metal ions (re)direct the electrons to the wrong target Chemistry 18 2012 15910 15920
155. H. Reiber Dynamics of brain-derived proteins in cerebrospinal fluid Clin. Chim. Acta 310 2001 173 186 (Pubitemid 32728347)
156. J.F. Poduslo, G.L. Curran, and C.T. Berg Macromolecular permeability across the blood nerve and blood brain barriers Proc. Natl. Acad. Sci. U. S. A. 91 1994 5705 5709 (Pubitemid 24174397)
157. B. Alies, E. Renaglia, M. Rózga, W. Bal, P. Faller, and C. Hureau Cu(II) affinity for the Alzheimer's peptide: tyrosine fluorescence studies revisited Anal. Chem. 85 2013 1561 1568
158. M. Rózga, M. Kłoniecki, A. Jabłonowska, M. Dadlez, and W. Bal The binding constant for amyloid Aβ40 peptide interaction with human serum albumin Biochem. Biophys. Res. Commun. 364 2007 714 718 (Pubitemid 350026521)
159. M. Rózga, and W. Bal The Cu(II)/Aβ/HSA model of control mechanism for copper-related amyloid neurotoxicity Chem. Res. Toxicol. 23 2010 298 308
160. D. Jiang, L. Zhang, G.P.G. Grant, C.G. Dudzik, S. Chen, S. Patel, Y. Hao, G.L. Millhauser, and F. Zhou The elevated copper binding strength of amyloid-β aggregates allows the sequestration of copper from albumin: a pathway to accumulation of copper in senile plaques Biochemistry 52 2013 547 556
161. T. Peters Jr. All about albumin 1995 Elsevier